The authors report a rare case of myocardial infarction secondary to coronary thromboses caused by the antiphospholipid syndrome. The relations between the cardiac pathology, especially the coronary disease, and antiphospholipid antibodies are recalled. The importance and methods of monitoring the anticoagulant therapy are emphasised.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Prevention of early thrombosis in transplanted vein model by encapsulation with tirofiban microneedle drug delivery system.
Biomed Mater
November 2024
Beijing Anzhen Hospital Affiliated to Capital Medical University, Coronary Heart Disease Surgery Center Zone 1, Beijing, People's Republic of China.
Early thrombosis following coronary artery bypass grafting (CABG) surgery leads to perioperative myocardial infarction, which causes difficulties for clinicians and patients. Moreover, once perioperative myocardial infarction occurs, the mortality rate is extremely high. In recent years, microneedle (MN) drug delivery systems have become a research hotspot with broad clinical application prospects.
View Article and Find Full Text PDFPrimary intraosseous meningioma: a case of early symptomatic calvarial origin meningioma.
J Surg Case Rep
October 2024
Department of Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Center, Elm and Carlton St. Buffalo, NY 14263, USA.
Primary intraosseous meningiomas are rare extradural tumors. They are typically slow-growing, painless, and asymptomatic until they cause a mass effect. We report a case of a calvarial primary intraosseous meningioma, which became symptomatic despite a very small size.
View Article and Find Full Text PDFBeneficial effects of CHF6467, a modified human nerve growth factor, in experimental neonatal hypoxic-ischaemic encephalopathy.
Br J Pharmacol
February 2025
Corporate Preclinical R&D, Chiesi Farmaceutici, Parma, Italy.
Article Synopsis
- Therapeutic hypothermia (TH) is now a standard treatment to reduce brain damage in newborns with hypoxic-ischaemic encephalopathy (HIE), but many still face high rates of death and disabilities.
- CHF6467 is a modified form of nerve growth factor (NGF) that does not cause pain and has shown protective effects on neurons in rodent models when used with hypothermia.
- This study suggests that combining intranasal administration of CHF6467 with TH significantly reduces brain damage and improves motor and memory function in neonatal HIE, making it a promising treatment option.
Painless recurrent orbital wall infarction secondary to sickle cell disease: A case report.
Am J Ophthalmol Case Rep
December 2024
King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Purpose: Describe the various presentations of the rare entity of orbital wall infarction secondary to sickle cell disease and highlight the importance of magnetic resonance imaging in differentiating the entity from other similar diagnoses.
Observation: A 4-year-old child presented to the hospital with bilateral recurrent painless orbital wall infarction secondary to sickle cell disease. Orbital wall infarctions have been described before in the literature; However, the painless and recurrent nature is intriguing.
Survey comparing the treatment of central retinal artery occlusion with hyperbaric oxygen in Australia and New Zealand with the recommended guidelines as outlined by the Undersea and Hyperbaric Medical Society.
Diving Hyperb Med
June 2024
Department of Hyperbaric Medicine, Fiona Stanley Hospital, Perth, Australia.
Introduction: Central retinal artery occlusion (CRAO) presents suddenly causing painless loss of vision that is often significant. Meaningful improvement in vision occurs in only 8% of patients with spontaneous reperfusion. Hyperbaric oxygen treatment (HBOT) is considered to be of benefit if commenced before retinal infarction occurs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!